Mainstay confirms its continued eligibility to the PEA-PME
on 12/01/2015 11:09
mainstay
Mainstay Medical achieves Quality System Certification
on 09/12/2014 14:25
Certification is an important step towards the commercialisation of ReActiv8.
Read more
Read more
Mainstay Medical - Interim Management Statement
on 06/11/2014 10:59
Continued progress towards commercialisation of ReActiv8®
Read more
Read more
Mainstay Medical announces half year financial results
on 28/08/2014 16:20
Momentum builds towards commercialisation of ReActiv8®
Read more
Read more
Mainstay Medical Announces Pre-IDE Submission for ReActiv8® to FDA
on 07/07/2014 11:26
Mainstay Medical continues progress towards the commercialisation of ReActiv8.
Read more
Read more
